Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Eskandar
Emad Eskandar, Nahant, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20120016436 | SYSTEM AND METHOD FOR DYNAMICALLY CONFIGURABLE DEEP BRAIN STIMULATION - A DBS system and method for predicting future neurological activity in a subject and administering a corrective electrical stimulation signal to prevent anticipated pathological neuronal activity. The DBS system includes an implantable electrode configured to both record neuronal activity from a target brain area in a subject and administer the corrective electric stimulation signal to the target area. The DBS system also includes a controller configured to determine the characteristics of the corrective electrical stimulation signal based on point process models of healthy and pathological neuronal activity in the target area. | 01-19-2012 |
Emad N. Eskandar, Nahant, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20100094382 | VISUAL PROSTHESIS AND METHODS OF CREATING VISUAL PERCEPTIONS - A visual prosthesis and methods of allowing a subject to view visual information from an artificial source are provided. The visual prosthesis has one or more electrodes operative to deliver electrical signals to a lateral geniculate nucleus of a mammal, a power supply operative to provide power to the electrodes, a visual information translator operatively connected to the electrode array, and a visual sensor operatively connected to the visual information translator. The visual prosthesis is operative to translate visual information into an electrical signal and transmit the electrical signal to electrodes to stimulate brain activity to recognize visual information. | 04-15-2010 |
Nasrin Ghouchi Eskandar, Prospect AU
| Patent application number | Description | Published |
|---|---|---|
| 20100136124 | NANOPARTICLE-COATED CAPSULE FORMULATION FOR DERMAL DRUG DELIVERY - A method and formulation for the delivery of an active substance to the skin (epidermis, including the stratum corneum and viable epidermis, and dermis) of a subject. The formulation comprises oil-based or aqueous droplets comprising the active substance within a coating of nanoparticles, particularly silica nanoparticles. The active substance may be suitable for the treatment of a disease or condition which is localised, or at least partially localised, to the skin (eg skin cancer, psoriasis, eczema, infections including bacterial and fungal infections, acne, dermatitis, inflammation, and rheumatoid arthritis). | 06-03-2010 |